Pill Identifier App

Clinical Trials Update: Dec. 5, 2008

-- Here are the latest clinical trials, courtesy of CenterWatch:


If you have histologically confirmed metastatic (Stage IV) melanoma of cutaneous origin, a life expectancy of greater than 12 weeks, and are at least 18 years old, you may be eligible for this study.

The research site is in Chicago, Ill.

More information

Please see http://www.centerwatch.com/patient/studies/cat791.html.


Fallopian Tube Cancer

If you have been diagnosed with ovarian, fallopian tube or primary peritoneal cancer, were relapse free at least 6 months after completion of first-line chemotherapy, and have at least one lesion that can be accurately measured in a least 1 dimension, you may qualify for this study.

The research site is in Augusta, Ga.

More information

Please see http://www.centerwatch.com/patient/studies/cat634.html.


Breast Cancer

If you are a postmenopausal female with stage IV or locally advanced breast cancer, and have an ECOG performance status of two or less, you may qualify for this study.

The research site is in St. Louis, Mo.

More information

Please see http://www.centerwatch.com/patient/studies/cat29.html.


Copyright 2008 CenterWatch. All rights reserved.

Posted: December 2008

View comments